BB Biotech’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | $152M | Buy |
|
|||||
|
2018
Q4 | $115M | Buy |
|
|||||
|
2018
Q3 | $120M | Buy |
|
|||||
|
2018
Q2 | $112M | Buy |
|
|||||
|
2018
Q1 | $120M | Sell |
|
|||||
|
2017
Q4 | $134M | Sell |
|
|||||
|
2017
Q3 | $131M | Sell |
|
|||||
|
2017
Q2 | $97.4M | Sell |
|
|||||
|
2017
Q1 | $63.6M | Buy |
|
|||||
|
2016
Q4 | $44.6M | Hold |
|
|||||
|
2016
Q3 | $80.7M | Hold |
|
|||||
|
2016
Q2 | $66.1M | Hold |
|
|||||
|
2016
Q1 | $74.8M | Buy |
|
|||||
|
2015
Q4 | $107M | Hold |
|
|||||
|
2015
Q3 | $91M | Buy |
|
|||||
|
2015
Q2 | $116M | Buy |
|
|||||
|
2015
Q1 | $87.2M | Buy |
|
|||||
|
2014
Q4 | $72.9M | Sell |
|
|||||
|
2014
Q3 | $61M | Buy |
|
|||||
|
2014
Q2 | $39.2M | Buy |
|
|||||
|
2014
Q1 | $31.6M | Hold |
|
|||||
|
2013
Q4 | $30.3M | Hold |
|
|||||
|
2013
Q3 | $30.2M | Buy |
|
|||||
|
2013
Q2 | $14.1M | Buy |
|